Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
boston
deals
fda
investing
national top stories
480 biomedical
acute myeloid leukemia
ally bridge group
alx oncology
arsenal medical
autoimmune diseases
berkeley lights
big data analytics
biotech ipos
blackrock
bob langer
cancer drugs
cancer immunotherapy
casdin capital
cd47
chronic kidney disease
chronic rhinosinusitis
covid-19
deerfield healthcare technology acquisitions
deerfield management company
diabetic nephropathy
drug delivery
europe blog main
europe top stories
eventide asset management
focal segmental glomerulosclerosis
genzyme
george whitesides
goldfinch bio
What
biotech
3
×
ipo
new
raised
3
×
company
million
raises
analysis
arrival
bio
bring
companies
days
debut
develop
developing
diseases
drug
employing
genetic
goldfinch
hasn’t
industry
ipos
kidney
late
later
lead
life
lyra
market
markets
medicines
momentum
nose
noses
persistently
public
research
runny
Language
unset
Current search:
biotech
×
raised
×
" clinical trials "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses